English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Custodero et al. conclude that N-terminal pro-brain natriuretic peptide (NT-proBNP) levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments in physical function and muscle strength in sepsis survivors [1]. A letter from Jiarong et al. has challenged this assertion, pointing to the exponential increase in the plasma level of NTproBNP with a declining glomerular filtration rate. As they have noted, it does not seem persuasive that NTproBNP could completely predict outcomes without adjusting for the covariate of renal function. They suggest that the relationship of NT-proBNP levels during the acute phase of sepsis and physical function and muscle strength outcomes in sepsis survivors be stratified based on the renal function [2]. In keeping with this, we would like to comment further. Nearly half of critically ill patients, especially with septic shock, have or develop acute kidney injury (AKI) and 20–25% need renal replacement therapy (RRT) within the first week of their stay [3]. In the Custodero study, the two cohorts (chronic critical illness [CCI] and rapid recovery [RAP]) had a considerable difference in the incidence of septic shock (36.5% vs 16.4%), so it would stand to reason that the rate of AKI and continuous renal replacement therapy (CRRT) was much lower in the RAP cohort when compared to the CCI cohort [1]. CRRT is performed using membranes that have a cut-off value of 35–40 kDa and therefore some quantity of NT-proBNP will be eliminated [4]. Because of its low molecular weight (8.5 kDa), NT-proBNP is likely to be effectively cleared by both highand low-flux membranes [4]. New highly adsorptive membranes (HAM) can adsorb many molecules with a molecular weight above 35 kDa and will increase this removal even further [4]. This could mislead patient prognostication by artificially decreasing NT-proBNP, but no studies have challenged this issue. Such studies should be done as there is already a long list of biomarkers in sepsis that are lacking reliability during CRRT [5]. As a consequence of the different rates of CRRT between the two cohorts, the reliability of NTproBNP to be a useful indicator of long-term impairments in physical function and muscle strength in sepsis survivors might be questioned.

critical care

N-terminal pro-brain natriuretic peptide levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments: some confounders to consider